Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ultrasound program aims to halve stillbirths by spotting tiny babies earlier.

NCT ID NCT03662178

Recruiting now Prevention Sponsor: Oxford University Hospitals NHS Trust Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a structured ultrasound program (OxGRIP) can help detect babies that are not growing well in the womb, which is a major risk factor for stillbirth. The program adds a routine scan at 36 weeks and extra scans for at-risk women. Researchers will compare stillbirth rates before and after the program in 56,000 pregnancies at Oxford University Hospitals.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
structured ultrasound scanning program
What this could lead to
If successful, this could reduce stillbirth rates by improving detection of growth-restricted babies during pregnancy.
What could go wrong
This is an observational study comparing outcomes before and after the program, not a randomized trial. Results may be influenced by other changes over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FETAL DEATH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fetal Death fetal growth restriction Perinatal Death pregnancy disorder with abortive outcome Stillbirth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FETAL DEATH FETAL GROWTH RESTRICTION FETAL GROWTH RETARDATION INTRAUTERINE GROWTH RESTRICTION PERINATAL DEATH SMALL FOR GESTATIONAL AGE STILLBIRTH

Contacts and locations

Locations

  • Oxford University Hospitals NHS Foundation Trust

    RECRUITING

    Oxford, Oxfordshire, OX3 9DU, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.